Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases.

摘要

3-hxygermylpropionic acid [O1/2)3GeCH2CH2CO2H]n ("3-0GP") has been known as a pharmaceutical agent, e.g for treating hepatopathy, preferably with a stabilizer and/or enhancer and can have immunity - accomodative actions. It is now found that 3-OGP is effective against a diabetes-dependent auto-immune disease and is used for manufacture of a medicament for its treatment or prevention. An activating carrier, e.g. hydroxypropyl cellulose, is preferably used in the composition, which may be in the form of tablets or capsules, in amount of 0.005 to 50 wt % of the 3-OGP. The preferable dose of the composition is 10 - 1500 mg/kg, or a daily adult dose of about 150 mg.